evidencegaps
Primary study · included by 1 review

Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis.

Monteiro 2024 · Monteiro Luis, Mariano Lorena C, Warnakulasuriya Saman · Oral diseases · 2024

Included by

Malignant Transformation of Oral Leukoplakia and Proliferative Verrucous Leukoplakia and Its Biomarker Predictors: A Systematic Umbrella Review.
Non-Cochrane · prognostic · 2026 · cited as Monteiro 2024 · Supplementary Table 3; ref 38
Outcome this study informsPooled effectEvidenceCertainty
Malignant transformation of OL
High podoplanin expression vs Low podoplanin expression
HR 3.72 [2.40, 5.76]6 studies · 546 participantsModerate

1 including review in total.